Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation.
Boriani
G
G
Institute of Cardiovascular Diseases, Bologna, Italy.
Biffi
M
M
Frabetti
L
L
Azzolini
U
U
Sabbatani
P
P
Bronzetti
G
G
Capucci
A
A
Magnani
B
B
D000328:Adult; D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000150:complications*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D014693:Ventricular Fibrillation / Q000139:chemically induced*; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone